{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:28:10Z","timestamp":1773865690873,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DHPS"],"DOI":"10.2147\/dhps.s142825","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T21:08:01Z","timestamp":1508965681000},"page":"93-104","source":"Crossref","is-referenced-by-count":17,"title":["Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial"],"prefix":"10.2147","volume":"Volume 9","author":[{"given":"Satoru","family":"Muto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-5234","authenticated-orcid":false,"given":"Tadashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moriyoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetsugu","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,10]]},"container-title":["Drug, Healthcare and Patient Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=39045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=39045","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T21:08:02Z","timestamp":1508965682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/long-term-safety-profile-of-tolvaptan-in-autosomal-dominant-polycystic-peer-reviewed-article-DHPS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dhps.s142825","relation":{},"ISSN":["1179-1365"],"issn-type":[{"value":"1179-1365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}